Cannabis: WHO just acknowledged historical misjudgment and heads towards global policy update

After thoroughly assessing Cannabis, THC and CBD in June, the WHO has just recognized its historical misjudgment that led to the placement of Cannabis medicines among heroin or fentanyl derivates, and will consider an international change of scheduling to adequate policies with evidence. #ECDD40

40th ECDD meeting in Geneva: pivotal moment for global Cannabis policies.

This week in Geneva for the first time ever, the WHO drugs committee has heard the voices of doctors, patients, and researchers, and started to weigh the harms and benefits of Cannabis neutrally.

Press release: WHO & Cannabis – 40th ECDD meeting

PRESS RELEASE • Cannabis policy reform: Activists from all continents converge in Geneva – Historical day inside of the World Health Organization.

Human Rights violations in the name of Drug Control: contribution to UN Human Rights

57 years of Global and Systematic Human Rights violations in the name of #DrugControl: Right to a Remedy and Reparation for Victims of Gross Violations of International Human Rights Law.

Crimson paper #3. The review(s).

Pre & Critical reviews: insights into the processes of the WHO scientific abuse liability assessment for drugs.

Pin It on Pinterest